about
Generics and cost-effective prescribing in Belgium: does bioequivalence always translate in therapeutic equivalence?Amiodarone-induced thyroid dysfunction: brand-name versus generic formulationsNarrow therapeutic index drugs: a clinical pharmacological consideration to flecainide.Comparative pharmacokinetic and pharmacodynamic evaluation of branded and generic formulations of meloxicam in healthy male volunteersSimulation of the AUC changes after generic substitution in patients.Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis.Lack of pharmacokinetic bioequivalence between generic and branded amoxicillin formulations. A post-marketing clinical study on healthy volunteers.Safety of flecainide.Is it rational, reasonable or excessive, and consistently applied? One view of the increasing FDA emphasis on safety first for the release and use of antiarrhythmic drugs for supraventricular arrhythmias."Appropriate Treatment" and Therapeutic Window in Spasticity Treatment with IncobotulinumtoxinA: From 100 to 1000 Units.
P2860
Q34614739-69A5E268-E027-4199-A65C-2C2AB60A831EQ35201288-66FD337B-2B5D-4D89-A886-C07F8D0550EEQ35547234-12489CB3-7B8A-48D3-AF5D-B55BC020C6FBQ37053912-D18EF65D-9E8C-4399-84B1-7B8EAB059403Q37116797-6D9098C4-E07E-4415-99A5-A65FF72A727CQ37269872-849041D3-388D-4A9F-AB9A-FC3ED2E5DA32Q37321407-BEA37ADC-2D69-4BFF-8632-1FADC92D4567Q37995638-DD30F4FE-DB58-4033-B7E4-F03907827332Q43926574-2C4BACE2-0752-404C-A242-6387288C2E13Q51732513-E789E8F1-D109-4CB4-A6E3-2A7712FA126B
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Issues in the use of generic antiarrhythmic drugs.
@ast
Issues in the use of generic antiarrhythmic drugs.
@en
Issues in the use of generic antiarrhythmic drugs.
@nl
type
label
Issues in the use of generic antiarrhythmic drugs.
@ast
Issues in the use of generic antiarrhythmic drugs.
@en
Issues in the use of generic antiarrhythmic drugs.
@nl
prefLabel
Issues in the use of generic antiarrhythmic drugs.
@ast
Issues in the use of generic antiarrhythmic drugs.
@en
Issues in the use of generic antiarrhythmic drugs.
@nl
P1476
Issues in the use of generic antiarrhythmic drugs.
@en
P2093
Reiffel JA
P356
10.1097/00001573-200101000-00004
P577
2001-01-01T00:00:00Z